Global Lyme Disease Testing Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Lyme Disease Testing market size was valued at US$ 196.2 million in 2023. With growing demand in downstream market, the Lyme Disease Testing is forecast to a readjusted size of US$ 311.6 million by 2030 with a CAGR of 6.8% during review period.
The research report highlights the growth potential of the global Lyme Disease Testing market. Lyme Disease Testing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Lyme Disease Testing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Lyme Disease Testing market.
Lyme disease is caused by the bacterium Borrelia burgdorferi and rarely, Borrelia mayonii. It is transmitted to humans through the bite of infected blacklegged ticks. Typical symptoms include fever, headache, fatigue, and a characteristic skin rash called erythema migrans. Lyme disease is usually diagnosed by serology. RIPL uses a modified 2-tier testing approach. The initial screening test is a combined IgG and IgM ELISA that detects antibodies against 2 Borrelia burgdorferi antigens – VlsE1 and pepC10.
Global key players of Lyme Disease Testing include Quidel Corporation, Roche Holding AG and Fujirebio(H.U. Group Holdings), etc. Global top three manufacturers hold a share about 25%. North America is the largest market of Lyme Disease Testing, with a share over 60%, followed by Asia-Pacific and Europe.
Key Features:
The report on Lyme Disease Testing market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Lyme Disease Testing market. It may include historical data, market segmentation by Type (e.g., ELISA, Western Blotting), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Lyme Disease Testing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Lyme Disease Testing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Lyme Disease Testing industry. This include advancements in Lyme Disease Testing technology, Lyme Disease Testing new entrants, Lyme Disease Testing new investment, and other innovations that are shaping the future of Lyme Disease Testing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Lyme Disease Testing market. It includes factors influencing customer ' purchasing decisions, preferences for Lyme Disease Testing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Lyme Disease Testing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Lyme Disease Testing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Lyme Disease Testing market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Lyme Disease Testing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Lyme Disease Testing market.
Market Segmentation:
Lyme Disease Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Lyme Disease Testing market size was valued at US$ 196.2 million in 2023. With growing demand in downstream market, the Lyme Disease Testing is forecast to a readjusted size of US$ 311.6 million by 2030 with a CAGR of 6.8% during review period.
The research report highlights the growth potential of the global Lyme Disease Testing market. Lyme Disease Testing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Lyme Disease Testing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Lyme Disease Testing market.
Lyme disease is caused by the bacterium Borrelia burgdorferi and rarely, Borrelia mayonii. It is transmitted to humans through the bite of infected blacklegged ticks. Typical symptoms include fever, headache, fatigue, and a characteristic skin rash called erythema migrans. Lyme disease is usually diagnosed by serology. RIPL uses a modified 2-tier testing approach. The initial screening test is a combined IgG and IgM ELISA that detects antibodies against 2 Borrelia burgdorferi antigens – VlsE1 and pepC10.
Global key players of Lyme Disease Testing include Quidel Corporation, Roche Holding AG and Fujirebio(H.U. Group Holdings), etc. Global top three manufacturers hold a share about 25%. North America is the largest market of Lyme Disease Testing, with a share over 60%, followed by Asia-Pacific and Europe.
Key Features:
The report on Lyme Disease Testing market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Lyme Disease Testing market. It may include historical data, market segmentation by Type (e.g., ELISA, Western Blotting), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Lyme Disease Testing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Lyme Disease Testing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Lyme Disease Testing industry. This include advancements in Lyme Disease Testing technology, Lyme Disease Testing new entrants, Lyme Disease Testing new investment, and other innovations that are shaping the future of Lyme Disease Testing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Lyme Disease Testing market. It includes factors influencing customer ' purchasing decisions, preferences for Lyme Disease Testing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Lyme Disease Testing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Lyme Disease Testing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Lyme Disease Testing market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Lyme Disease Testing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Lyme Disease Testing market.
Market Segmentation:
Lyme Disease Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- ELISA
- Western Blotting
- PCR
- Others
- Hospital and Testing Agency
- Personal
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Quidel Corporation
- Roche Holding AG
- Fujirebio(H.U. Group Holdings)
- ZEUS Scientific
- IGeneX
- Thermo Fisher Scientific
- Everlywell
- Oxford Immunotec Global PLC(PerkinElmer)
- BioMerieux
- Bio-Rad Laboratories
- T2 Biosystems
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Lyme Disease Testing Market Size 2019-2030
2.1.2 Lyme Disease Testing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Lyme Disease Testing Segment by Type
2.2.1 ELISA
2.2.2 Western Blotting
2.2.3 PCR
2.2.4 Others
2.3 Lyme Disease Testing Market Size by Type
2.3.1 Lyme Disease Testing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Lyme Disease Testing Market Size Market Share by Type (2019-2024)
2.4 Lyme Disease Testing Segment by Application
2.4.1 Hospital and Testing Agency
2.4.2 Personal
2.5 Lyme Disease Testing Market Size by Application
2.5.1 Lyme Disease Testing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Lyme Disease Testing Market Size Market Share by Application (2019-2024)
3 LYME DISEASE TESTING MARKET SIZE BY PLAYER
3.1 Lyme Disease Testing Market Size Market Share by Players
3.1.1 Global Lyme Disease Testing Revenue by Players (2019-2024)
3.1.2 Global Lyme Disease Testing Revenue Market Share by Players (2019-2024)
3.2 Global Lyme Disease Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LYME DISEASE TESTING BY REGIONS
4.1 Lyme Disease Testing Market Size by Regions (2019-2024)
4.2 Americas Lyme Disease Testing Market Size Growth (2019-2024)
4.3 APAC Lyme Disease Testing Market Size Growth (2019-2024)
4.4 Europe Lyme Disease Testing Market Size Growth (2019-2024)
4.5 Middle East & Africa Lyme Disease Testing Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Lyme Disease Testing Market Size by Country (2019-2024)
5.2 Americas Lyme Disease Testing Market Size by Type (2019-2024)
5.3 Americas Lyme Disease Testing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lyme Disease Testing Market Size by Region (2019-2024)
6.2 APAC Lyme Disease Testing Market Size by Type (2019-2024)
6.3 APAC Lyme Disease Testing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Lyme Disease Testing by Country (2019-2024)
7.2 Europe Lyme Disease Testing Market Size by Type (2019-2024)
7.3 Europe Lyme Disease Testing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Lyme Disease Testing by Region (2019-2024)
8.2 Middle East & Africa Lyme Disease Testing Market Size by Type (2019-2024)
8.3 Middle East & Africa Lyme Disease Testing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LYME DISEASE TESTING MARKET FORECAST
10.1 Global Lyme Disease Testing Forecast by Regions (2025-2030)
10.1.1 Global Lyme Disease Testing Forecast by Regions (2025-2030)
10.1.2 Americas Lyme Disease Testing Forecast
10.1.3 APAC Lyme Disease Testing Forecast
10.1.4 Europe Lyme Disease Testing Forecast
10.1.5 Middle East & Africa Lyme Disease Testing Forecast
10.2 Americas Lyme Disease Testing Forecast by Country (2025-2030)
10.2.1 United States Lyme Disease Testing Market Forecast
10.2.2 Canada Lyme Disease Testing Market Forecast
10.2.3 Mexico Lyme Disease Testing Market Forecast
10.2.4 Brazil Lyme Disease Testing Market Forecast
10.3 APAC Lyme Disease Testing Forecast by Region (2025-2030)
10.3.1 China Lyme Disease Testing Market Forecast
10.3.2 Japan Lyme Disease Testing Market Forecast
10.3.3 Korea Lyme Disease Testing Market Forecast
10.3.4 Southeast Asia Lyme Disease Testing Market Forecast
10.3.5 India Lyme Disease Testing Market Forecast
10.3.6 Australia Lyme Disease Testing Market Forecast
10.4 Europe Lyme Disease Testing Forecast by Country (2025-2030)
10.4.1 Germany Lyme Disease Testing Market Forecast
10.4.2 France Lyme Disease Testing Market Forecast
10.4.3 UK Lyme Disease Testing Market Forecast
10.4.4 Italy Lyme Disease Testing Market Forecast
10.4.5 Russia Lyme Disease Testing Market Forecast
10.5 Middle East & Africa Lyme Disease Testing Forecast by Region (2025-2030)
10.5.1 Egypt Lyme Disease Testing Market Forecast
10.5.2 South Africa Lyme Disease Testing Market Forecast
10.5.3 Israel Lyme Disease Testing Market Forecast
10.5.4 Turkey Lyme Disease Testing Market Forecast
10.5.5 GCC Countries Lyme Disease Testing Market Forecast
10.6 Global Lyme Disease Testing Forecast by Type (2025-2030)
10.7 Global Lyme Disease Testing Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Quidel Corporation
11.1.1 Quidel Corporation Company Information
11.1.2 Quidel Corporation Lyme Disease Testing Product Offered
11.1.3 Quidel Corporation Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Quidel Corporation Main Business Overview
11.1.5 Quidel Corporation Latest Developments
11.2 Roche Holding AG
11.2.1 Roche Holding AG Company Information
11.2.2 Roche Holding AG Lyme Disease Testing Product Offered
11.2.3 Roche Holding AG Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Roche Holding AG Main Business Overview
11.2.5 Roche Holding AG Latest Developments
11.3 Fujirebio(H.U. Group Holdings)
11.3.1 Fujirebio(H.U. Group Holdings) Company Information
11.3.2 Fujirebio(H.U. Group Holdings) Lyme Disease Testing Product Offered
11.3.3 Fujirebio(H.U. Group Holdings) Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Fujirebio(H.U. Group Holdings) Main Business Overview
11.3.5 Fujirebio(H.U. Group Holdings) Latest Developments
11.4 ZEUS Scientific
11.4.1 ZEUS Scientific Company Information
11.4.2 ZEUS Scientific Lyme Disease Testing Product Offered
11.4.3 ZEUS Scientific Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 ZEUS Scientific Main Business Overview
11.4.5 ZEUS Scientific Latest Developments
11.5 IGeneX
11.5.1 IGeneX Company Information
11.5.2 IGeneX Lyme Disease Testing Product Offered
11.5.3 IGeneX Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 IGeneX Main Business Overview
11.5.5 IGeneX Latest Developments
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Information
11.6.2 Thermo Fisher Scientific Lyme Disease Testing Product Offered
11.6.3 Thermo Fisher Scientific Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Thermo Fisher Scientific Main Business Overview
11.6.5 Thermo Fisher Scientific Latest Developments
11.7 Everlywell
11.7.1 Everlywell Company Information
11.7.2 Everlywell Lyme Disease Testing Product Offered
11.7.3 Everlywell Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Everlywell Main Business Overview
11.7.5 Everlywell Latest Developments
11.8 Oxford Immunotec Global PLC(PerkinElmer)
11.8.1 Oxford Immunotec Global PLC(PerkinElmer) Company Information
11.8.2 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Product Offered
11.8.3 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Oxford Immunotec Global PLC(PerkinElmer) Main Business Overview
11.8.5 Oxford Immunotec Global PLC(PerkinElmer) Latest Developments
11.9 BioMerieux
11.9.1 BioMerieux Company Information
11.9.2 BioMerieux Lyme Disease Testing Product Offered
11.9.3 BioMerieux Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 BioMerieux Main Business Overview
11.9.5 BioMerieux Latest Developments
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Information
11.10.2 Bio-Rad Laboratories Lyme Disease Testing Product Offered
11.10.3 Bio-Rad Laboratories Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Bio-Rad Laboratories Main Business Overview
11.10.5 Bio-Rad Laboratories Latest Developments
11.11 T2 Biosystems
11.11.1 T2 Biosystems Company Information
11.11.2 T2 Biosystems Lyme Disease Testing Product Offered
11.11.3 T2 Biosystems Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 T2 Biosystems Main Business Overview
11.11.5 T2 Biosystems Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Lyme Disease Testing Market Size 2019-2030
2.1.2 Lyme Disease Testing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Lyme Disease Testing Segment by Type
2.2.1 ELISA
2.2.2 Western Blotting
2.2.3 PCR
2.2.4 Others
2.3 Lyme Disease Testing Market Size by Type
2.3.1 Lyme Disease Testing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Lyme Disease Testing Market Size Market Share by Type (2019-2024)
2.4 Lyme Disease Testing Segment by Application
2.4.1 Hospital and Testing Agency
2.4.2 Personal
2.5 Lyme Disease Testing Market Size by Application
2.5.1 Lyme Disease Testing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Lyme Disease Testing Market Size Market Share by Application (2019-2024)
3 LYME DISEASE TESTING MARKET SIZE BY PLAYER
3.1 Lyme Disease Testing Market Size Market Share by Players
3.1.1 Global Lyme Disease Testing Revenue by Players (2019-2024)
3.1.2 Global Lyme Disease Testing Revenue Market Share by Players (2019-2024)
3.2 Global Lyme Disease Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 LYME DISEASE TESTING BY REGIONS
4.1 Lyme Disease Testing Market Size by Regions (2019-2024)
4.2 Americas Lyme Disease Testing Market Size Growth (2019-2024)
4.3 APAC Lyme Disease Testing Market Size Growth (2019-2024)
4.4 Europe Lyme Disease Testing Market Size Growth (2019-2024)
4.5 Middle East & Africa Lyme Disease Testing Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Lyme Disease Testing Market Size by Country (2019-2024)
5.2 Americas Lyme Disease Testing Market Size by Type (2019-2024)
5.3 Americas Lyme Disease Testing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lyme Disease Testing Market Size by Region (2019-2024)
6.2 APAC Lyme Disease Testing Market Size by Type (2019-2024)
6.3 APAC Lyme Disease Testing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Lyme Disease Testing by Country (2019-2024)
7.2 Europe Lyme Disease Testing Market Size by Type (2019-2024)
7.3 Europe Lyme Disease Testing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Lyme Disease Testing by Region (2019-2024)
8.2 Middle East & Africa Lyme Disease Testing Market Size by Type (2019-2024)
8.3 Middle East & Africa Lyme Disease Testing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL LYME DISEASE TESTING MARKET FORECAST
10.1 Global Lyme Disease Testing Forecast by Regions (2025-2030)
10.1.1 Global Lyme Disease Testing Forecast by Regions (2025-2030)
10.1.2 Americas Lyme Disease Testing Forecast
10.1.3 APAC Lyme Disease Testing Forecast
10.1.4 Europe Lyme Disease Testing Forecast
10.1.5 Middle East & Africa Lyme Disease Testing Forecast
10.2 Americas Lyme Disease Testing Forecast by Country (2025-2030)
10.2.1 United States Lyme Disease Testing Market Forecast
10.2.2 Canada Lyme Disease Testing Market Forecast
10.2.3 Mexico Lyme Disease Testing Market Forecast
10.2.4 Brazil Lyme Disease Testing Market Forecast
10.3 APAC Lyme Disease Testing Forecast by Region (2025-2030)
10.3.1 China Lyme Disease Testing Market Forecast
10.3.2 Japan Lyme Disease Testing Market Forecast
10.3.3 Korea Lyme Disease Testing Market Forecast
10.3.4 Southeast Asia Lyme Disease Testing Market Forecast
10.3.5 India Lyme Disease Testing Market Forecast
10.3.6 Australia Lyme Disease Testing Market Forecast
10.4 Europe Lyme Disease Testing Forecast by Country (2025-2030)
10.4.1 Germany Lyme Disease Testing Market Forecast
10.4.2 France Lyme Disease Testing Market Forecast
10.4.3 UK Lyme Disease Testing Market Forecast
10.4.4 Italy Lyme Disease Testing Market Forecast
10.4.5 Russia Lyme Disease Testing Market Forecast
10.5 Middle East & Africa Lyme Disease Testing Forecast by Region (2025-2030)
10.5.1 Egypt Lyme Disease Testing Market Forecast
10.5.2 South Africa Lyme Disease Testing Market Forecast
10.5.3 Israel Lyme Disease Testing Market Forecast
10.5.4 Turkey Lyme Disease Testing Market Forecast
10.5.5 GCC Countries Lyme Disease Testing Market Forecast
10.6 Global Lyme Disease Testing Forecast by Type (2025-2030)
10.7 Global Lyme Disease Testing Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Quidel Corporation
11.1.1 Quidel Corporation Company Information
11.1.2 Quidel Corporation Lyme Disease Testing Product Offered
11.1.3 Quidel Corporation Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Quidel Corporation Main Business Overview
11.1.5 Quidel Corporation Latest Developments
11.2 Roche Holding AG
11.2.1 Roche Holding AG Company Information
11.2.2 Roche Holding AG Lyme Disease Testing Product Offered
11.2.3 Roche Holding AG Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Roche Holding AG Main Business Overview
11.2.5 Roche Holding AG Latest Developments
11.3 Fujirebio(H.U. Group Holdings)
11.3.1 Fujirebio(H.U. Group Holdings) Company Information
11.3.2 Fujirebio(H.U. Group Holdings) Lyme Disease Testing Product Offered
11.3.3 Fujirebio(H.U. Group Holdings) Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Fujirebio(H.U. Group Holdings) Main Business Overview
11.3.5 Fujirebio(H.U. Group Holdings) Latest Developments
11.4 ZEUS Scientific
11.4.1 ZEUS Scientific Company Information
11.4.2 ZEUS Scientific Lyme Disease Testing Product Offered
11.4.3 ZEUS Scientific Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 ZEUS Scientific Main Business Overview
11.4.5 ZEUS Scientific Latest Developments
11.5 IGeneX
11.5.1 IGeneX Company Information
11.5.2 IGeneX Lyme Disease Testing Product Offered
11.5.3 IGeneX Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 IGeneX Main Business Overview
11.5.5 IGeneX Latest Developments
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Information
11.6.2 Thermo Fisher Scientific Lyme Disease Testing Product Offered
11.6.3 Thermo Fisher Scientific Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Thermo Fisher Scientific Main Business Overview
11.6.5 Thermo Fisher Scientific Latest Developments
11.7 Everlywell
11.7.1 Everlywell Company Information
11.7.2 Everlywell Lyme Disease Testing Product Offered
11.7.3 Everlywell Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Everlywell Main Business Overview
11.7.5 Everlywell Latest Developments
11.8 Oxford Immunotec Global PLC(PerkinElmer)
11.8.1 Oxford Immunotec Global PLC(PerkinElmer) Company Information
11.8.2 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Product Offered
11.8.3 Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Oxford Immunotec Global PLC(PerkinElmer) Main Business Overview
11.8.5 Oxford Immunotec Global PLC(PerkinElmer) Latest Developments
11.9 BioMerieux
11.9.1 BioMerieux Company Information
11.9.2 BioMerieux Lyme Disease Testing Product Offered
11.9.3 BioMerieux Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 BioMerieux Main Business Overview
11.9.5 BioMerieux Latest Developments
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Information
11.10.2 Bio-Rad Laboratories Lyme Disease Testing Product Offered
11.10.3 Bio-Rad Laboratories Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Bio-Rad Laboratories Main Business Overview
11.10.5 Bio-Rad Laboratories Latest Developments
11.11 T2 Biosystems
11.11.1 T2 Biosystems Company Information
11.11.2 T2 Biosystems Lyme Disease Testing Product Offered
11.11.3 T2 Biosystems Lyme Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 T2 Biosystems Main Business Overview
11.11.5 T2 Biosystems Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Lyme Disease Testing Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of ELISA
Table 3. Major Players of Western Blotting
Table 4. Major Players of PCR
Table 5. Major Players of Others
Table 6. Lyme Disease Testing Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Lyme Disease Testing Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Lyme Disease Testing Market Size Market Share by Type (2019-2024)
Table 9. Lyme Disease Testing Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Lyme Disease Testing Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Lyme Disease Testing Market Size Market Share by Application (2019-2024)
Table 12. Global Lyme Disease Testing Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Lyme Disease Testing Revenue Market Share by Player (2019-2024)
Table 14. Lyme Disease Testing Key Players Head office and Products Offered
Table 15. Lyme Disease Testing Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Lyme Disease Testing Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Lyme Disease Testing Market Size Market Share by Regions (2019-2024)
Table 20. Global Lyme Disease Testing Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Lyme Disease Testing Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Lyme Disease Testing Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Lyme Disease Testing Market Size Market Share by Country (2019-2024)
Table 24. Americas Lyme Disease Testing Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Lyme Disease Testing Market Size Market Share by Type (2019-2024)
Table 26. Americas Lyme Disease Testing Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Lyme Disease Testing Market Size Market Share by Application (2019-2024)
Table 28. APAC Lyme Disease Testing Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Lyme Disease Testing Market Size Market Share by Region (2019-2024)
Table 30. APAC Lyme Disease Testing Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Lyme Disease Testing Market Size Market Share by Type (2019-2024)
Table 32. APAC Lyme Disease Testing Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Lyme Disease Testing Market Size Market Share by Application (2019-2024)
Table 34. Europe Lyme Disease Testing Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Lyme Disease Testing Market Size Market Share by Country (2019-2024)
Table 36. Europe Lyme Disease Testing Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Lyme Disease Testing Market Size Market Share by Type (2019-2024)
Table 38. Europe Lyme Disease Testing Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Lyme Disease Testing Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Lyme Disease Testing Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Lyme Disease Testing Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Lyme Disease Testing Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Lyme Disease Testing Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Lyme Disease Testing Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Lyme Disease Testing Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Lyme Disease Testing
Table 47. Key Market Challenges & Risks of Lyme Disease Testing
Table 48. Key Industry Trends of Lyme Disease Testing
Table 49. Global Lyme Disease Testing Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Lyme Disease Testing Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Lyme Disease Testing Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Lyme Disease Testing Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Quidel Corporation Details, Company Type, Lyme Disease Testing Area Served and Its Competitors
Table 54. Quidel Corporation Lyme Disease Testing Product Offered
Table 55. Quidel Corporation Lyme Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Quidel Corporation Main Business
Table 57. Quidel Corporation Latest Developments
Table 58. Roche Holding AG Details, Company Type, Lyme Disease Testing Area Served and Its Competitors
Table 59. Roche Holding AG Lyme Disease Testing Product Offered
Table 60. Roche Holding AG Main Business
Table 61. Roche Holding AG Lyme Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Roche Holding AG Latest Developments
Table 63. Fujirebio(H.U. Group Holdings) Details, Company Type, Lyme Disease Testing Area Served and Its Competitors
Table 64. Fujirebio(H.U. Group Holdings) Lyme Disease Testing Product Offered
Table 65. Fujirebio(H.U. Group Holdings) Main Business
Table 66. Fujirebio(H.U. Group Holdings) Lyme Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Fujirebio(H.U. Group Holdings) Latest Developments
Table 68. ZEUS Scientific Details, Company Type, Lyme Disease Testing Area Served and Its Competitors
Table 69. ZEUS Scientific Lyme Disease Testing Product Offered
Table 70. ZEUS Scientific Main Business
Table 71. ZEUS Scientific Lyme Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. ZEUS Scientific Latest Developments
Table 73. IGeneX Details, Company Type, Lyme Disease Testing Area Served and Its Competitors
Table 74. IGeneX Lyme Disease Testing Product Offered
Table 75. IGeneX Main Business
Table 76. IGeneX Lyme Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. IGeneX Latest Developments
Table 78. Thermo Fisher Scientific Details, Company Type, Lyme Disease Testing Area Served and Its Competitors
Table 79. Thermo Fisher Scientific Lyme Disease Testing Product Offered
Table 80. Thermo Fisher Scientific Main Business
Table 81. Thermo Fisher Scientific Lyme Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Thermo Fisher Scientific Latest Developments
Table 83. Everlywell Details, Company Type, Lyme Disease Testing Area Served and Its Competitors
Table 84. Everlywell Lyme Disease Testing Product Offered
Table 85. Everlywell Main Business
Table 86. Everlywell Lyme Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Everlywell Latest Developments
Table 88. Oxford Immunotec Global PLC(PerkinElmer) Details, Company Type, Lyme Disease Testing Area Served and Its Competitors
Table 89. Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Product Offered
Table 90. Oxford Immunotec Global PLC(PerkinElmer) Main Business
Table 91. Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Oxford Immunotec Global PLC(PerkinElmer) Latest Developments
Table 93. BioMerieux Details, Company Type, Lyme Disease Testing Area Served and Its Competitors
Table 94. BioMerieux Lyme Disease Testing Product Offered
Table 95. BioMerieux Main Business
Table 96. BioMerieux Lyme Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. BioMerieux Latest Developments
Table 98. Bio-Rad Laboratories Details, Company Type, Lyme Disease Testing Area Served and Its Competitors
Table 99. Bio-Rad Laboratories Lyme Disease Testing Product Offered
Table 100. Bio-Rad Laboratories Main Business
Table 101. Bio-Rad Laboratories Lyme Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Bio-Rad Laboratories Latest Developments
Table 103. T2 Biosystems Details, Company Type, Lyme Disease Testing Area Served and Its Competitors
Table 104. T2 Biosystems Lyme Disease Testing Product Offered
Table 105. T2 Biosystems Lyme Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. T2 Biosystems Main Business
Table 107. T2 Biosystems Latest Developments
Table 1. Lyme Disease Testing Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of ELISA
Table 3. Major Players of Western Blotting
Table 4. Major Players of PCR
Table 5. Major Players of Others
Table 6. Lyme Disease Testing Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Lyme Disease Testing Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Lyme Disease Testing Market Size Market Share by Type (2019-2024)
Table 9. Lyme Disease Testing Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Lyme Disease Testing Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Lyme Disease Testing Market Size Market Share by Application (2019-2024)
Table 12. Global Lyme Disease Testing Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Lyme Disease Testing Revenue Market Share by Player (2019-2024)
Table 14. Lyme Disease Testing Key Players Head office and Products Offered
Table 15. Lyme Disease Testing Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Lyme Disease Testing Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Lyme Disease Testing Market Size Market Share by Regions (2019-2024)
Table 20. Global Lyme Disease Testing Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Lyme Disease Testing Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Lyme Disease Testing Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Lyme Disease Testing Market Size Market Share by Country (2019-2024)
Table 24. Americas Lyme Disease Testing Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Lyme Disease Testing Market Size Market Share by Type (2019-2024)
Table 26. Americas Lyme Disease Testing Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Lyme Disease Testing Market Size Market Share by Application (2019-2024)
Table 28. APAC Lyme Disease Testing Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Lyme Disease Testing Market Size Market Share by Region (2019-2024)
Table 30. APAC Lyme Disease Testing Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Lyme Disease Testing Market Size Market Share by Type (2019-2024)
Table 32. APAC Lyme Disease Testing Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Lyme Disease Testing Market Size Market Share by Application (2019-2024)
Table 34. Europe Lyme Disease Testing Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Lyme Disease Testing Market Size Market Share by Country (2019-2024)
Table 36. Europe Lyme Disease Testing Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Lyme Disease Testing Market Size Market Share by Type (2019-2024)
Table 38. Europe Lyme Disease Testing Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Lyme Disease Testing Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Lyme Disease Testing Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Lyme Disease Testing Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Lyme Disease Testing Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Lyme Disease Testing Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Lyme Disease Testing Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Lyme Disease Testing Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Lyme Disease Testing
Table 47. Key Market Challenges & Risks of Lyme Disease Testing
Table 48. Key Industry Trends of Lyme Disease Testing
Table 49. Global Lyme Disease Testing Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Lyme Disease Testing Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Lyme Disease Testing Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Lyme Disease Testing Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Quidel Corporation Details, Company Type, Lyme Disease Testing Area Served and Its Competitors
Table 54. Quidel Corporation Lyme Disease Testing Product Offered
Table 55. Quidel Corporation Lyme Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Quidel Corporation Main Business
Table 57. Quidel Corporation Latest Developments
Table 58. Roche Holding AG Details, Company Type, Lyme Disease Testing Area Served and Its Competitors
Table 59. Roche Holding AG Lyme Disease Testing Product Offered
Table 60. Roche Holding AG Main Business
Table 61. Roche Holding AG Lyme Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Roche Holding AG Latest Developments
Table 63. Fujirebio(H.U. Group Holdings) Details, Company Type, Lyme Disease Testing Area Served and Its Competitors
Table 64. Fujirebio(H.U. Group Holdings) Lyme Disease Testing Product Offered
Table 65. Fujirebio(H.U. Group Holdings) Main Business
Table 66. Fujirebio(H.U. Group Holdings) Lyme Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Fujirebio(H.U. Group Holdings) Latest Developments
Table 68. ZEUS Scientific Details, Company Type, Lyme Disease Testing Area Served and Its Competitors
Table 69. ZEUS Scientific Lyme Disease Testing Product Offered
Table 70. ZEUS Scientific Main Business
Table 71. ZEUS Scientific Lyme Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. ZEUS Scientific Latest Developments
Table 73. IGeneX Details, Company Type, Lyme Disease Testing Area Served and Its Competitors
Table 74. IGeneX Lyme Disease Testing Product Offered
Table 75. IGeneX Main Business
Table 76. IGeneX Lyme Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. IGeneX Latest Developments
Table 78. Thermo Fisher Scientific Details, Company Type, Lyme Disease Testing Area Served and Its Competitors
Table 79. Thermo Fisher Scientific Lyme Disease Testing Product Offered
Table 80. Thermo Fisher Scientific Main Business
Table 81. Thermo Fisher Scientific Lyme Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Thermo Fisher Scientific Latest Developments
Table 83. Everlywell Details, Company Type, Lyme Disease Testing Area Served and Its Competitors
Table 84. Everlywell Lyme Disease Testing Product Offered
Table 85. Everlywell Main Business
Table 86. Everlywell Lyme Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Everlywell Latest Developments
Table 88. Oxford Immunotec Global PLC(PerkinElmer) Details, Company Type, Lyme Disease Testing Area Served and Its Competitors
Table 89. Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Product Offered
Table 90. Oxford Immunotec Global PLC(PerkinElmer) Main Business
Table 91. Oxford Immunotec Global PLC(PerkinElmer) Lyme Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Oxford Immunotec Global PLC(PerkinElmer) Latest Developments
Table 93. BioMerieux Details, Company Type, Lyme Disease Testing Area Served and Its Competitors
Table 94. BioMerieux Lyme Disease Testing Product Offered
Table 95. BioMerieux Main Business
Table 96. BioMerieux Lyme Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. BioMerieux Latest Developments
Table 98. Bio-Rad Laboratories Details, Company Type, Lyme Disease Testing Area Served and Its Competitors
Table 99. Bio-Rad Laboratories Lyme Disease Testing Product Offered
Table 100. Bio-Rad Laboratories Main Business
Table 101. Bio-Rad Laboratories Lyme Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Bio-Rad Laboratories Latest Developments
Table 103. T2 Biosystems Details, Company Type, Lyme Disease Testing Area Served and Its Competitors
Table 104. T2 Biosystems Lyme Disease Testing Product Offered
Table 105. T2 Biosystems Lyme Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. T2 Biosystems Main Business
Table 107. T2 Biosystems Latest Developments
LIST OF FIGURES
Figure 1. Lyme Disease Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Lyme Disease Testing Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Lyme Disease Testing Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Lyme Disease Testing Sales Market Share by Country/Region (2023)
Figure 8. Lyme Disease Testing Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Lyme Disease Testing Market Size Market Share by Type in 2023
Figure 10. Lyme Disease Testing in Hospital and Testing Agency
Figure 11. Global Lyme Disease Testing Market: Hospital and Testing Agency (2019-2024) & ($ Millions)
Figure 12. Lyme Disease Testing in Personal
Figure 13. Global Lyme Disease Testing Market: Personal (2019-2024) & ($ Millions)
Figure 14. Global Lyme Disease Testing Market Size Market Share by Application in 2023
Figure 15. Global Lyme Disease Testing Revenue Market Share by Player in 2023
Figure 16. Global Lyme Disease Testing Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Lyme Disease Testing Market Size 2019-2024 ($ Millions)
Figure 18. APAC Lyme Disease Testing Market Size 2019-2024 ($ Millions)
Figure 19. Europe Lyme Disease Testing Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Lyme Disease Testing Market Size 2019-2024 ($ Millions)
Figure 21. Americas Lyme Disease Testing Value Market Share by Country in 2023
Figure 22. United States Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Lyme Disease Testing Market Size Market Share by Region in 2023
Figure 27. APAC Lyme Disease Testing Market Size Market Share by Type in 2023
Figure 28. APAC Lyme Disease Testing Market Size Market Share by Application in 2023
Figure 29. China Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Lyme Disease Testing Market Size Market Share by Country in 2023
Figure 36. Europe Lyme Disease Testing Market Size Market Share by Type (2019-2024)
Figure 37. Europe Lyme Disease Testing Market Size Market Share by Application (2019-2024)
Figure 38. Germany Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Lyme Disease Testing Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Lyme Disease Testing Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Lyme Disease Testing Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 52. APAC Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 53. Europe Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 55. United States Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 56. Canada Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 59. China Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 60. Japan Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 61. Korea Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 63. India Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 64. Australia Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 65. Germany Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 66. France Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 67. UK Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 68. Italy Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 69. Russia Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 70. Spain Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 73. Israel Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 76. Global Lyme Disease Testing Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Lyme Disease Testing Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Lyme Disease Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Lyme Disease Testing Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Lyme Disease Testing Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Lyme Disease Testing Sales Market Share by Country/Region (2023)
Figure 8. Lyme Disease Testing Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Lyme Disease Testing Market Size Market Share by Type in 2023
Figure 10. Lyme Disease Testing in Hospital and Testing Agency
Figure 11. Global Lyme Disease Testing Market: Hospital and Testing Agency (2019-2024) & ($ Millions)
Figure 12. Lyme Disease Testing in Personal
Figure 13. Global Lyme Disease Testing Market: Personal (2019-2024) & ($ Millions)
Figure 14. Global Lyme Disease Testing Market Size Market Share by Application in 2023
Figure 15. Global Lyme Disease Testing Revenue Market Share by Player in 2023
Figure 16. Global Lyme Disease Testing Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Lyme Disease Testing Market Size 2019-2024 ($ Millions)
Figure 18. APAC Lyme Disease Testing Market Size 2019-2024 ($ Millions)
Figure 19. Europe Lyme Disease Testing Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Lyme Disease Testing Market Size 2019-2024 ($ Millions)
Figure 21. Americas Lyme Disease Testing Value Market Share by Country in 2023
Figure 22. United States Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Lyme Disease Testing Market Size Market Share by Region in 2023
Figure 27. APAC Lyme Disease Testing Market Size Market Share by Type in 2023
Figure 28. APAC Lyme Disease Testing Market Size Market Share by Application in 2023
Figure 29. China Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Lyme Disease Testing Market Size Market Share by Country in 2023
Figure 36. Europe Lyme Disease Testing Market Size Market Share by Type (2019-2024)
Figure 37. Europe Lyme Disease Testing Market Size Market Share by Application (2019-2024)
Figure 38. Germany Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Lyme Disease Testing Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Lyme Disease Testing Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Lyme Disease Testing Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Lyme Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 52. APAC Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 53. Europe Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 55. United States Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 56. Canada Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 59. China Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 60. Japan Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 61. Korea Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 63. India Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 64. Australia Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 65. Germany Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 66. France Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 67. UK Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 68. Italy Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 69. Russia Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 70. Spain Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 73. Israel Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Lyme Disease Testing Market Size 2025-2030 ($ Millions)
Figure 76. Global Lyme Disease Testing Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Lyme Disease Testing Market Size Market Share Forecast by Application (2025-2030)
